Virtu KCG Holdings’s TherapeuticsMD TXMD Stock Holding History

Virtu KCG Holdings’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$157K	Buy	+597	New	+$150K	﹤0.01%	2273
2017 Q1	–	Sell	-1,990	Closed	-$574K	–	3747
2016 Q4	$574K	Buy	1,990 +869	+78%	+$269K	0.01%	1354
2016 Q3	$382K	Buy	1,121 +850	+314%	+$310K	0.01%	1666
2016 Q2	$115K	Sell	271 -66	-20%	-$27.2K	﹤0.01%	2506
2016 Q1	$108K	Sell	337 -99	-23%	-$33.8K	﹤0.01%	2315
2015 Q4	$226K	Sell	436 -178	-29%	-$65.7K	﹤0.01%	2544
2015 Q3	$180K	Sell	614 -48	-7%	-$17.1K	﹤0.01%	2614
2015 Q2	$260K	Buy	+662	New	+$234K	﹤0.01%	2258
2015 Q1	–	Sell	-365	Closed	-$81K	–	3888
2014 Q4	$81K	Buy	365 +156	+75%	+$32.2K	﹤0.01%	3301
2014 Q3	$49K	Sell	209 -415	-67%	-$105K	﹤0.01%	3348
2014 Q2	$138K	Buy	+624	New	+$139K	﹤0.01%	3200
2013 Q4	–	Sell	-215	Closed	-$31K	–	4269
2013 Q3	$31K	Buy	+215	New	+$26K	﹤0.01%	3571

Other funds holding TXMD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Virtu KCG Holdings's TXMD Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in TherapeuticsMD (TXMD) in Q2 2017: 597 shares worth $157K. The stake represents ﹤0.01% of the portfolio and ranks #2273 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in TXMD as recently as Q4 2016.

Virtu KCG Holdings first reported a position in TXMD in Q3 2013 and has held it in 12 quarters since. The position peaked at $574K in Q4 2016. 117 funds tracked by Wall St. Rank hold TXMD as of Q2 2017.

Virtu KCG Holdings held 597 shares of TherapeuticsMD worth $157K as of Q2 2017.
TherapeuticsMD was a new Virtu KCG Holdings position in Q2 2017.
TherapeuticsMD made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2273 holding.
Virtu KCG Holdings first reported a position in TherapeuticsMD in Q3 2013 and has held it in 12 quarters since.
Virtu KCG Holdings's TherapeuticsMD position peaked at $574K in Q4 2016.
117 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.